Mendivil, Joan http://orcid.org/0000-0003-1139-0078
Malmenäs, Mia
Haeussler, Katrin
Hunger, Matthias
Jain, Gagan
Devercelli, Giovanna
Funding for this research was provided by:
Takeda Pharmaceutical Company
Article History
Accepted: 11 January 2021
First Online: 1 March 2021
Declarations
:
: This ITC was sponsored by Shire Human Genetic Therapies, Inc., a Takeda company, Lexington, MA, USA.
: Joan Mendivil, Gagan Jain, and Giovanna Devercelli are full-time employees of Takeda. Mia Malmenäs, Katrin Haeussler, and Matthias Hunger are full-time employees of ICON plc.
: Not applicable.
: Not applicable.
: Not applicable.
: The datasets supporting the results reported in this article will be available 3 months after the submission of a request to researchers who provide a methodologically sound proposal. The data will be provided after its de-identification, in compliance with applicable privacy laws, data protection, and requirements for consent and anonymization.
: Not applicable.
: JM and KH contributed to data acquisition. All authors contributed to study design, data analysis and/or interpretation, drafting of the manuscript or revising for important intellectual content, and approval of the final draft.